Plant stanols and sterols
Plant stanols and sterols, also called phytosterols,
occur naturally in plant sources such as peanuts, beans, olive oil and peanut oil.
Phytosterols, like stigmasterol from soybean oil, are of current interest because they lower
blood cholesterol levels, although the response varies widely.
Phytosterols have the same basic structure as
cholesterol, but differ in the side chains attached to carbon 17.
Sterols that are fully saturated (no double bonds) are called "stanols". For example, stigmastanol has the same structure as stigmasterol, but without the double bonds. When fatty acids react with the hydroxyl at carbon 3 they form "sterol esters". Phytosterols appear to work by interfering with the absorption of cholesterol by the intestines, resulting in lower blood cholesterol levels.
Garlic
Several studies have reported that raw garlic has cholesterol-lowering properties, but the effects
do not appear to be long-lasting. Garlic capsules and other forms of garlic appear to be ineffective
at lowering cholesterol. In addition, raw garlic's pungent smell and strong taste can
produce bad breath and bad body odor. One scientific study in 2000 concluded that
garlic is superior to placebo in reducing total cholesterol levels, but
the size of the effect is modest, and the robustness of the effect is debatable.
Therefore, the use of garlic for hypercholesterolemia is of questionable value.[9]
A more recent study in 2007 found that there were no statistically significant
changes in blood cholesterol readings from eating the equivalent of one clove of raw garlic per day.[12]
Niacin
Niacin is also known as nicotinic acid or vitamin B3.
It is a water-soluble vitamin whose derivatives such as NADH
play essential roles in energy metabolism.
Niacin lowers total and LDL cholesterol and raises HDL cholesterol.
It also can also lower triglycerides. The dose needed for treatment is about 100 times more
than the Recommended Daily Allowance for niacin.
High doses (75 mg or more) of niacin can cause side effects such as a burning, tingling sensation in the
face and chest, and red or "flushed" skin. High doses of niacin are associated with toxic side effects
that include worsening of diabetes control and exacerbation of peptic ulcer disease and gout.[15]
Treatment for high cholesterol with niacin must be done under a doctor's care.
Statins
The enzyme hydroxy-methylglutaryl-coenzyme A reductase (HMG-CoA reductase or HMGR)
is responsible for making cholesterol in the liver.
The level of cholesterol in the blood normally serves as a feed-back mechanism to determine
how much cholesterol is made.
Cholesterol inhibits the activity of HMGR by degrading the enzyme, but insulin stimulates the
removal of phosphates and indirectly activates HMGR which results in extra cholesterol production.
Statins are synthetic drugs developed by pharmaceutical companies that block HMG-CoA reductase thereby lowering the level of cholesterol in the blood. Statins belong to the class of drugs called HMGR inhibitors. Some of the most common statin drugs are Lipitor, Crestor, Pravachol, and Zocor. The drugs are successful at lowering cholesterol, and they reduce morbidity and mortality in patients with risk factors for atherosclerotic disease. Unfortunately, 5% of statin users experience gastrointestinal and muscular problems. Statins inhibit not only cholesterol synthesis, but also synthesis of other substances such as Coenzyme Q10 (CoQ10) which leads to a reduction of high energy phosphates, anaerobe metabolism and mitochondrial dysfunction that sometimes cause muscle damage. Bayer Pharmaceutical Division withdrew its cholesterol-lowering drug Baycol (cerivastatin) from the U.S. market in 2001 because of reports of fatal rhabdomyolysis, a severe muscle adverse reaction involving destruction or degeneration of skeletal muscle. The following table shows the most commonly prescribed statins and their attributes.
Statin | Manufacturer & Approval | Attributes |
---|---|---|
![]() Mevacor (lovastatin) |
Merck and generic manufacturers Approved by the FDA in 1987 |
Can reduce LDL by 30 to 40 percent. Best for patients with moderate elevation of LDL (130 to 159 mg/dL). Inexpensive |
![]() Pravachol (pravastatin) |
Bristol-Myers, Squibb and generic manufacturers Approved by the FDA in 1991 |
Least likely to cause drug interactions. Best for patients with borderline high LDL (120 to 140 mg/dL) and who take other medications. |
![]() Zocor (simvastatin) |
Merck and generic manufacturers Approved by the FDA in 1991 |
Effective at raising HDL cholesterol. Greater risk of muscle injury at its highest dosage. Best for patients with moderately high LDL (150 to 180 mg/dL) and low LDL (< 40 mg/dL). |
![]() Lipitor (atorvastatin) |
Pfizer Patent expiration in 2010 Approved by the FDA in 1996 |
Can reduce LDL up to 55 percent. Best for patients with high LDL (160 to 190 mg/dL) Expensive |
![]() Lescol (fluvastatin) |
Novartis Approved by the FDA in 2000 |
Low risk of side effects. Best for patients with borderline high LDL (120 to 140 mg/dL). |
![]() Crestor (rosuvastatin) |
AstraZeneca Approved by the FDA in 2003 |
Potent LDL reduction of up to 60 percent. Best for patients with high LDL (160 to 190 mg/dL) Expensive |